Skip to Content

Spencer Pharmaceutical Inc SPPH

Morningstar Rating
$0.00 0.00 (0.00%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

SPPH is trading at a 60% discount.
Price
$0.00
Fair Value
$6.12
Uncertainty
Extreme
1-Star Price
$9.25
5-Star Price
$2.71
Economic Moat
Cssr
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if SPPH is a good fit for your portfolio.

Trading Information

Previous Close Price
$0.00
Day Range
$0.000.00
52-Week Range
$0.000.00
Bid/Ask
/
Market Cap
$1.34
Volume/Avg
250 / 7,750

Key Statistics

Price/Earnings (Normalized)
Price/Sales
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Spencer Pharmaceutical Inc specializing in the identification of new drug delivery applications and focuses on patented formulation of existing drugs from the incubation to the developmental stages or synthesized drugs to cross the blood-brain barrier.
Sector
Healthcare
Industry
Biotechnology
Stock Style Box
Total Number of Employees
15

Valuation

Metric
SPPH
Price/Earnings (Normalized)
Price/Book Value
Price/Sales
Price/Cash Flow
Price/Earnings
No chart available

Financial Strength

Metric
SPPH
Quick Ratio
0.37
Current Ratio
0.53
Interest Coverage
Quick Ratio
No chart available

Profitability

Metric
SPPH
Return on Assets (Normalized)
−51.06%
Return on Equity (Normalized)
−65.81%
Return on Invested Capital (Normalized)
−61.63%
Return on Assets
No chart available
See how this stock stacks up to its competitors with Morningstar Investor

Biotechnology Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
NVO
Novo Nordisk A/S ADRMnxgqkthqNxxc$564.6 Bil
REGN
Regeneron Pharmaceuticals IncKwwqnqpkCgcqvp$102.8 Bil
VRTX
Vertex Pharmaceuticals IncRzmqgnkHyvwbs$102.5 Bil
MRNA
Moderna IncWxztcjtYwp$41.0 Bil
ARGX
argenx SE ADRHpklxtsbvCkxf$22.8 Bil
BNTX
BioNTech SE ADRPmfpsjcqSdgkq$21.7 Bil
ALNY
Alnylam Pharmaceuticals IncFqgbzfwGmbysx$18.8 Bil
BMRN
Biomarin Pharmaceutical IncHzgldhlxbQrhdtl$17.4 Bil
RPRX
Royalty Pharma PLC Class AMyjxwkdrqDnvgmc$12.6 Bil
INCY
Incyte CorpMwkjrtbxBggmbwh$12.1 Bil

Sponsor Center